Amyotrophic lateral sclerosis research program support services

Active Awarded Last action

Contract number
HT942726FE026
Awardee
Awarding agency
Obligated
$141,787

Award facts

Contract value 58% obligated
$245,554.07 Current and potential, with all options
Completion date 48% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $141,787

About this award

The Defense Health Agency issued a $245,554.07 delivery order to Leidos, Inc. on May 1, 2026, for amylotrophic lateral sclerosis research program support services, with performance concluding April 30, 2027.

Place of performance is Frederick, MD. The order is priced on a cost-plus-fixed-fee basis. Ultimate completion date is April 30, 2027.

Quick answers

Who was awarded contract HT942726FE026?

HT942726FE026 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on May 1, 2026.

How much is contract HT942726FE026 worth?

The government has obligated $141,787 on HT942726FE026. Its current value, with exercised options, is $245,554.

Is contract HT942726FE026 an order under another contract?

Yes. HT942726FE026 is a delivery order under HT942523D0002, an indefinite delivery contract.

Was contract HT942726FE026 competed?

The extent of competition for HT942726FE026 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award